Costs and cost-effectiveness of family CBT versus individual CBT in clinically anxious children

Clinical Child Psychology and Psychiatry

Volumn 13, Issue 4, 2008, Pages 543-564

  Bodden, Denise H M ^a   Dirksen, Carmen D ^b   Bögels, Susan M ^c   Nauta, Maaike H ^d   De Haan, Else ^e   Ringrose, Jaap ^f   Appelboom, Carla ^g   Brinkman, Andries G ^h   Appelboom Geerts, Karen C M M J ^f  

^a UTRECHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f Mental Health Care ^*  (Netherlands)

^g Mental Health Services Lentis   (Netherlands)

^h Institute of Mental Health Care   (Netherlands)

Author keywords

Anxiety disorders; Children; Cost effectiveness; Costs

Indexed keywords

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SENSITIVITY ANALYSIS; TREATMENT OUTCOME;

ADOLESCENT; ANXIETY DISORDERS; CHILD; COGNITIVE THERAPY; COST OF ILLNESS; COST-BENEFIT ANALYSIS; FAMILY THERAPY; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MODELS, ECONOMETRIC; NETHERLANDS; QUALITY-ADJUSTED LIFE YEARS;

EID: 53949089075     PISSN: 13591045     EISSN: 14617021     Source Type: Journal    
DOI: 10.1177/1359104508090602     Document Type: Article

References (51)

1. Barrett, P.M., Dadds, M.R., & Rapee, R.M. (1996). Family treatment of childhood anxiety: A controlled trial. Journal of Consulting and Clinical Psychology, 64, 333-342.
2. Bernstein, G.A., Borchardt, C.M., & Perwien, A.R. (1996). Anxiety disorders in children and adolescents: A review of the past 10 years. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1110-1119.
3. Bodden, D.H.M., Bögels, S.M., Nauta, M.H., de Haan, E., Ringrose, J., Appelboom, C., et al. (in press). Child versus family cognitive-behavioral therapy in clinically anxious youth: An efficacy and partial effectiveness study. Journal of the American Academy of Child and Adolescent Psychiatry.
4. Bodden, D.H.M., Dirksen, C.D., & Bögels, S.M. (2008). Societal burden of clinically anxious youth referred for treatment: A cost-of-illness study. Journal of Abnormal Child Psychology, 36, 487-497.
5. Bögels, S.M., & Siqueland, L. (2006). Family cognitive behaviour therapy for children and adolescents with clinical anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 2, 134-141.
6. Brazier, J., Roberts, J., Tsuchiya, A., & Busschbach, J. (2004). A comparison of the EQ-5D and SF-6d across seven patient groups. Health Economics, 13, 873-884.
7. Briggs, A.H., Wonderling, D.E., & Mooney, C.Z. (1997). Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Economics, 6, 327-340.
8. Brooks, R. with the EuroQol Group. (1996). EuroQol: The current state of play. Health Policy, 37, 53-72.
9. Brown, T.A., Di Nardo, P.A., Lehman, C.L., & Campbell, L.A. (2001). Reliability of DSM-IV anxiety and mood disorders: Implications for the classification of emotional disorders. Journal of Abnormal Psychology, 110, 49-58.
10. Cartwright-Hatton, S., Roberts, C., Chitsabesan, P., Fothergill, C., & Harrington, R. (2004). Systematic review of the efficacy of cognitive behaviour therapies for childhood and adolescent anxiety disorders. British Journal of Clinical Psychology, 43, 421-436.
11. De Wit, G.A., Busschbach, J.J.V., & De Charro, F.T.H. (2000). Sensitivity and perspective in the valuation of health status: Whose values count ? Health Economics, 9, 109-126.
12. Di Nardo, P.A., Brown, T.A., & Barlow, D.H. (1994). Anxiety Disorders Interview Schedule for DSM-IV; Lifetime version (ADIS-IV-L). San Antonio, TX: Psychological Corporation.
13. Dolan, P. (1997). Modelling valuations for EuroQol health states. Medical Care, 35, 1096-1108.
14. Drummond, M.F., O'Brien, B.J., Stoddart, G.L., & Torrance, G.W. (1997). Methods for the economic evaluation of health care programmes. Oxford, UK: Oxford Medical.
15. Dupont, R.L., Rice, D.P., Miller, L.S., Shiraki, S.S., Rowland, C.R., & Harwood, H.J. (1996). Economic costs of anxiety disorders. Anxiety, 2, 167-172.
16. Efron, B., & Tibshirani, R.J. (1993). An introduction to the bootstrap. New York: Chapman and Hall.
17. EuroQol Group. (1990). EuroQol - A new facility for the measurement of health related quality of life. Health Policy, 16, 199-208.
18. Fals-Stewart, W., Yates, B.T., & Klostermann, K. (2005). Assessing the costs, benefits, cost-benefit ratio, and cost-effectiveness of marital and family treatments: Why we should and how we can. Journal of Family Psychology, 19, 28-39.
19. Freer, C.B. (1980). Health diaries: A method of collecting health information. Journal of the Royal College of General Practitioners, 30, 279-282.
20. Gold, M.R., Siegel, J.E., Russell, L.B., & Weinstein, M.C. (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
21. Goossens, M.E.J.B., Rutten-van Mölken, M.P.M.H., Vlaeyen, J.W.S., & Van der Linden, S.M.J.P. (2000). The cost diary: A method to measure direct and indirect costs in cost-effectiveness research. Journal of Clinical Epidemiology, 53, 688-695.
22. Greenberg, P.E., Sisitsky, T., Kessler, R.C., Finkelstein, S.N., Berndt, E.R., Davidson, J.R.T., et al. (1999). The economic burden of anxiety disorders in the 1990s. Journal of Clinical Psychiatry, 60, 427-435.
23. Heuzenroeder, L., Donnelly, M., Haby, M.M., Mihalopoulos, C., Rossell, R., Carter, R., et al. (2004). Cost-effectiveness of psychological and pharmacological interventions for generalised anxiety disorder and panic disorder. Australian and New Zealand Journal of Psychiatry, 38, 602-612.
24. In-Albon, T., & Schneider, S. (2006). Psychotherapy of childhood anxiety disorders: A meta-analysis. Psychotherapy and Psychosomatics, 76, 15-24.
25. Issakidis, C., Sanderson, K., Corry, J., Andrews, G., & Lapsley, H. (2004). Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders. Psychological Medicine, 34, 19-35.
26. Jacobs, P., & Roos, N. (1990). Standard cost lists for healthcare in Canada. Pharmacoeconomics, 15, 551-560.
27. Knapp, M. (1997). Economic evaluations and interventions for children and adolescents with mental health problems. Journal of Child Psychology and Psychiatry, 38, 3-25.
28. Lamers, L.M., McDonnell, J., Stalmeier, P.F., Krabbe, P.F., & Busschbach, J.J.V. (2006). The Dutch tariff: Results and arguments for an effective design for national EQ-5D valuation studies. Health Economics, 15, 1121-1132.
29. Lamers, L.M., Stalmeier, P.F.M., McDonnell, J., Krabbe, P.F.M., & Busschbach, J.J.V. (2005). Kwaliteit van leven meten in economische evaluaties: Het Nederlands EQ-5D-tarief. Nederlands Tijdschrift voor Geneeskunde, 149, 1574-1580.
30. Leon, A.C., Portera, L., & Weissman, M.M. (1995). The social costs of anxiety disorders. British Journal of Psychiatry, 27, 19-22.
31. Manca, A., Hawkins, N., & Sculpher, M.J. (2005). Estimating mean QALYs in trail-based cost-effectiveness analysis: The importance of controlling for baseline utility. Health Economics, 14, 487-496.
32. Marciniak, M., Lage, M.J., Landbloom, R.P., Dunayevich, E., & Bowman, L. (2004). Medical and productivity costs of anxiety disorders: Case control study. Depression and Anxiety, 19, 112-120.
33. Matza, L.S., Secnik, K., Mannix, S., & Sallee, F.R. (2005). Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK. Pharmacoeconomics, 23, 777-790.
34. McCrone, P., Knapp, M., Proudfoot, J., Ryden, C., Cavanagh, K., Shapiro, D.A. et al. (2004). Cost-effectiveness of computerised cognitive behavioural therapy for anxiety and depression in primary care: Randomised control trial. British Journal of Psychiatry, 185, 55-62.
35. Meltzer-Brody, S., & Davidson, J.R.T. (2000). Completeness of response and quality of life in mood and anxiety disorders. Depression and Anxiety, 12 (Suppl 1). 95-101.
36. Mendlowicz, M.V., & Stein, M.B. (2000). Quality of life in individuals with anxiety disorders. American Journal of Psychiatry, 157, 669-682.
37. Nauta, M.H., Scholing, A., Emmelkamp, P.M., & Minderaa, R.B. (2003). Cognitive-behavioural therapy for anxiety disordered children in a clinical setting: No additional effect of a cognitive parent training. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1270-1278.
38. Oostenbrink, J.B., Koopmanschap, M.A., & Rutten, F.F.H. (2005). Handleiding voor kostenonderzoek: Methoden en richtlijnprijzen voor economische evaluaties in de gezondheidszorg. Amstelveen: College voor zorgverzekeringen.
39. Polder, J.J., Takken, J., Meerding, W.J., Kommer, G.J., & Stokx, L.J. (2002). Kosten van ziekten in Nederland. Retrieved 2002 from http://www.rivm.nl/kostenvanziekten.
40. Poley, M.J., Stolk, E.A., Langemeijer, R.A.T.M., Molenaar, J.C., & Busschbach, J.J.V. (2001). The cost-effectiveness of neonatal surgery and subsequent treatment for congenital anorectal malformations. Journal of Pediatric Surgery, 36, 1471-1478.
41. Ramsey, S., Willke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., et al. (2005). Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA task force report. Value in Health, 5, 521-533.
42. Sach, T.H., & Barton, G.R. (2007). Interpreting parental proxy reports of (health-related) quality of life for children with unilateral cochlear implants. International Journal of Pediatric Otorhinolaryngology, 71, 435-445.
43. Silverman, W.K., & Albano, A.M. (1996). Anxiety Disorders Interview Schedule for DSM-IV Child Version, Child Interview Schedule. San Antonio, TX: Psychological Corporation.
44. Silverman, W.K., Saavedra, L.M., & Pina, A.A. (2001). Test-retest reliability of anxiety symptoms and diagnoses with anxiety disorders interview schedule for DSM-IV: Child and parent versions. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 937-943.
45. Steinglass, P. (1996). Family therapy's future. Family Process, 35, 403-405.
46. Stolk, E.A., Busschbach, J.J.V., & Vogels,T. (2000). Performance of the EuroQol in children with imperforate anus. Quality of Life Research, 9, 29-38.
47. Tudor Edwards, R., & Thalanany, M. (2001). Trade-offs in the conduct of economic evaluations of child mental health services. Mental Health Services Research, 3, 99-105.
48. Van Asselt, A.D.I., Dirksen, C.D., Arntz, A., Giesen-Bloo, J.H., Van Dyck, R., et al. (in press). Outpatient psychotherapy for borderline personality disorder. Cost-effectiveness of schema-focused therapy versus transference-focused psychotherapy. British Journal of Psychiatry.
49. Verhulst, F.C., Van der Ende, J., Ferdinand, R.F., & Kasius, M.C. (1997). The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents. Archives of General Psychiatry, 54, 329-336.
50. Weiss, B., Catron, T., Harris, V., & Phung, T.M. (1999). The effectiveness of traditional child psychotherapy. Journal of Consulting and Clinical Psychology, 67, 82-94.
51. Willems, D.C.M., Joore, M.A., Hendriks, J.J.E., Wouters, E.F.M., & Severens, J.L. (2007). Cost-effectiveness of a nurse-led telemonitoring intervention based on peak expiratory flow measurements in asthmatics: Results of a randomised controlled trial. Cost Effectiveness and resource Allocation, 5 (10). 5-10 [doi: 10.1186/1478-7547].